| abstract |
Compositions, methods and kits for the prognosis, diagnosis and monitoring of an angiogenesis dependent disease in a human or animal. In accordance with the prognosis method, or for monitoring the state of an angiogenesis dependent disease, the concentration of one or more angiogenesis associated factors in a biological sample of a patient diagnosed with an angiogenesis dependent disease is measured, alone or in combination with other angiogenesis associated factors. For angiogenesis dependent disease diagnosis, the concentration of one or more angiogenesis associated growth factors and one or more angiogenesis associated inhibitory factors, such as angiostatin, are determined. |